Yeaman Kevin J's Form 4/A amendment
AmendedDolby Laboratories, Inc. (DLB) · filed Nov 1, 2024
- Accession no.
- 0000950170-24-120226
- Filed
- Nov 1, 2024
- Rule 10b5-1 plan
- Checked
- Original filed
- Oct 17, 2024
This filing lists no transactions. It carries over 4 transactions from the original filing that it did not restate. Open-market sales total $2.11M.
This amendment restates part of 0000950170-24-115380 (filed Oct 17, 2024). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yeaman Kevin JCIK 0001200469 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0000950170-24-115380 (filed Oct 17, 2024).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Class A Common Stock | MOption exerciseAcquired | +28,512 | $62.32 | +$1,776,867.84 | 112,233 | Indirect | |
| Oct 15, 2024 | Class A Common Stock | SSaleDisposed | −18,696 | $73.90F3 | −$1,381,634.4 | 93,537 | Indirect | |
| Oct 15, 2024 | Class A Common Stock | SSaleDisposed | −9,816 | $74.55F4 | −$731,782.8 | 83,721 | Indirect |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Class A Common Stock | MOption exerciseDisposed | −28,512 | $0.00 | $0 | 57,888 | Indirect |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F3
The shares were sold in multiple transactions at prices ranging from $73.38 to $74.375, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F4
The shares were sold in multiple transactions at prices ranging from $74.38 to $74.74, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
This amendment has no footnotes.
Remarks
On October 17, 2024, the reporting person filed a Form 4 which inadvertently left off a holding line reporting the indirect holdings by his son of 2.5592 shares.